ResMed | RMD - Stock


ResMed reported $945.8M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Ansell USD 584.7M 126.8M Jun/2025
Artivion USD 103.36M 5.37M Jun/2026
AtriCure USD 83.92M 2.78M Jun/2026
Baxter International USD 2.26B 57M Jun/2026
Cochlear AUD 499.4M 107.8M Jun/2025
Cooper Companies USD 896.4M 20M Mar/2026
CSL USD 6.47B 327M Jun/2025
Dexcom USD 726.4M 32.8M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
Fisher Paykel Healthcare NZD 327.3M 31.6M Jun/2026
Globus Medical USD 810.9M 38.3M Jun/2026
Haemonetics USD 306.74M 369K Jun/2026
Idexx Laboratories USD 391.58M 9.18M Jun/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 484.8M 22.3M Jun/2026
Integra LifeSciences USD 492M 3.03M Jun/2026
Intuitive Surgical USD 2.03B 83.6M Jun/2026
Medtronic USD 6.22B 264M Jun/2026
Philips EUR 3.22B 106M Jun/2026
Ramsay Health Care AUD 404.4M 25M Jun/2025
ResMed USD 945.8M 33.93M Jun/2026
Sigma Healthcare AUD 324.85M 25.65M Jan/2023
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Steris USD 712.1M 80.3M Jun/2026
Teleflex USD 351.91M 28.95M Jun/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026